Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
317.48B | 298.86B | 278.78B | 257.89B | 240.95B | Gross Profit |
74.60B | 67.24B | 61.57B | 56.84B | 54.85B | EBIT |
22.03B | 20.68B | 18.27B | 16.84B | 15.97B | EBITDA |
27.14B | 24.67B | 22.50B | 22.50B | 21.98B | Net Income Common Stockholders |
21.15B | 11.85B | 11.38B | 9.13B | 8.57B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
38.16B | 43.42B | 41.24B | 45.35B | 44.33B | Total Assets |
258.70B | 257.60B | 240.84B | 228.91B | 234.54B | Total Debt |
49.24B | 60.03B | 26.64B | 28.83B | 44.67B | Net Debt |
13.58B | 24.70B | -6.10B | -11.52B | 6.34B | Total Liabilities |
117.05B | 128.68B | 88.09B | 85.95B | 99.38B | Stockholders Equity |
139.46B | 124.35B | 134.69B | 125.67B | 119.55B |
Cash Flow | Free Cash Flow | |||
7.19B | 5.03B | 1.24B | 9.17B | 4.61B | Operating Cash Flow |
16.24B | 16.15B | 13.52B | 15.91B | 14.79B | Investing Cash Flow |
4.40B | -9.21B | -15.52B | 4.89B | -16.11B | Financing Cash Flow |
-21.44B | -5.45B | -5.91B | -17.87B | 12.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥637.80B | 29.20 | 15.61% | 0.78% | 6.23% | 78.16% | |
73 Outperform | $2.21T | 19.75 | 8.56% | 1.69% | 3.60% | 6.61% | |
71 Outperform | ¥3.88T | 34.36 | 1.27% | 6.51% | -0.45% | ||
71 Outperform | ¥1.15T | 27.47 | 1.92% | 8.34% | 4.41% | ||
69 Neutral | $5.30T | 16.77 | 11.70% | 0.93% | 0.40% | 152.61% | |
63 Neutral | $1.18T | 22.04 | 14.69% | 2.36% | 13.33% | 12.72% | |
59 Neutral | $9.97B | 10.09 | -6.54% | 3.08% | 7.41% | -11.60% |